These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 21618021)
21. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic. Piekielna J; De Marco R; Gentilucci L; Cerlesi MC; Calo' G; Tömböly C; Artali R; Janecka A Biopolymers; 2016 May; 106(3):309-17. PubMed ID: 27038094 [TBL] [Abstract][Full Text] [Related]
22. Involvement of multiple µ-opioid receptor subtypes on the presynaptic or postsynaptic inhibition of spinal pain transmission. Mizoguchi H; Takagi H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S Peptides; 2014 Jan; 51():15-25. PubMed ID: 24512946 [TBL] [Abstract][Full Text] [Related]
23. [Endomorphins--endogenous ligands of the mu-opioid receptor]. Perlikowska R; Fichna J; Janecka A Postepy Biochem; 2009; 55(4):388-94. PubMed ID: 20201352 [TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships of modified C-terminal endomorphin-2 analogues by molecular dynamics simulations. Wang YC; Wu YC; Chen JW; Huang LS; Tsai FR; Hwang CC J Mol Graph Model; 2008 Nov; 27(4):489-96. PubMed ID: 18930674 [TBL] [Abstract][Full Text] [Related]
25. Structural function of C-terminal amidation of endomorphin. Conformational comparison of mu-selective endomorphin-2 with its C-terminal free acid, studied by 1H-NMR spectroscopy, molecular calculation, and X-ray crystallography. In Y; Minoura K; Tomoo K; Sasaki Y; Lazarus LH; Okada Y; Ishida T FEBS J; 2005 Oct; 272(19):5079-97. PubMed ID: 16176278 [TBL] [Abstract][Full Text] [Related]
26. Endomorphin-1: induction of motor behavior and lack of receptor desensitization. Mehta A; Bot G; Reisine T; Chesselet MF J Neurosci; 2001 Jun; 21(12):4436-42. PubMed ID: 11404430 [TBL] [Abstract][Full Text] [Related]
27. Conformational analysis of endomorphin-2 by molecular dynamics methods. Leitgeb B; Otvös F; Tóth G Biopolymers; 2003 Apr; 68(4):497-511. PubMed ID: 12666175 [TBL] [Abstract][Full Text] [Related]
28. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse. Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796 [TBL] [Abstract][Full Text] [Related]
29. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Hackler L; Zadina JE; Ge LJ; Kastin AJ Peptides; 1997; 18(10):1635-9. PubMed ID: 9437727 [TBL] [Abstract][Full Text] [Related]
30. Solution conformation of mu-selective dermorphin and delta-selective deltorphin-I in phospholipid micelles, studied by NMR spectroscopy and molecular dynamics simulations. Segawa M; Ohno Y; Doi M; Ishida T; Iwashita T Int J Pept Protein Res; 1995 Jul; 46(1):37-46. PubMed ID: 7558595 [TBL] [Abstract][Full Text] [Related]
31. The inverse type II β-turn on D-Trp-Phe, a pharmacophoric motif for MOR agonists. Gentilucci L; Tolomelli A; De Marco R; Spampinato S; Bedini A; Artali R ChemMedChem; 2011 Sep; 6(9):1640-53. PubMed ID: 21721130 [TBL] [Abstract][Full Text] [Related]
32. Endomorphin-1 and endomorphin-2 activate mu-opioid receptors in myenteric neurons of the guinea-pig small intestine. Tonini M; Fiori E; Balestra B; Spelta V; D'Agostino G; Di Nucci A; Brecha NC; Sternini C Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):686-9. PubMed ID: 9879730 [TBL] [Abstract][Full Text] [Related]
33. Synthesis of stereoisomeric analogues of endomorphin-2, H-Tyr-Pro-Phe-Phe-NH(2), and examination of their opioid receptor binding activities and solution conformation. Okada Y; Fukumizu A; Takahashi M; Shimizu Y; Tsuda Y; Yokoi T; Bryant SD; Lazarus LH Biochem Biophys Res Commun; 2000 Sep; 276(1):7-11. PubMed ID: 11006073 [TBL] [Abstract][Full Text] [Related]
34. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla. Mizoguchi H; Narita M; Wu H; Narita M; Suzuki T; Nagase H; Tseng LF Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217 [TBL] [Abstract][Full Text] [Related]
35. Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice. Fichna J; Janecka A; Piestrzeniewicz M; Costentin J; do Rego JC Neuropsychopharmacology; 2007 Apr; 32(4):813-21. PubMed ID: 16823383 [TBL] [Abstract][Full Text] [Related]
36. Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist properties. Fujita Y; Tsuda Y; Li T; Motoyama T; Takahashi M; Shimizu Y; Yokoi T; Sasaki Y; Ambo A; Kita A; Jinsmaa Y; Bryant SD; Lazarus LH; Okada Y J Med Chem; 2004 Jul; 47(14):3591-9. PubMed ID: 15214786 [TBL] [Abstract][Full Text] [Related]
37. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity. Heyl DL; Schmitter SJ; Bouzit H; Johnson TW; Hepp AM; Kurtz KR; Mousigian C Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499 [TBL] [Abstract][Full Text] [Related]
38. Endomorphins fully activate a cloned human mu opioid receptor. Gong J; Strong JA; Zhang S; Yue X; DeHaven RN; Daubert JD; Cassel JA; Yu G; Mansson E; Yu L FEBS Lett; 1998 Nov; 439(1-2):152-6. PubMed ID: 9849897 [TBL] [Abstract][Full Text] [Related]
39. In vitro characterization of novel peptide inhibitors of endomorphin-degrading enzymes in the rat brain. Fichna J; Janecka A; Bailly L; Marsais F; Costentin J; do Rego JC Chem Biol Drug Des; 2006 Sep; 68(3):173-5. PubMed ID: 17062015 [TBL] [Abstract][Full Text] [Related]